ArticleCureus2025
Ovarian Sertoli-Leydig Tumour in a Postmenopausal Female With Virilisation: Magnetic Resonance Imaging Findings.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sertoli-Leydig cell tumours (SLCTs) of the ovary are uncommon sex cord-stromal tumours that may cause virilisation and menometrorrhagia. Herein, we describe the magnetic resonance imaging features of SLCT in a 75-year-old female who exhibited virilisation with elevated androgen and oestrogen levels. The tumour appeared as a well-defined multilobulated mass. Measuring 8 cm in diameter with flow voids and cavitation, and showed high signal intensity in the early and delayed phases. The uterine myometrium showed high signal intensity and a clear junctional zone on T2-weighted images, and the clitoris was enlarged. A solid ovarian mass demonstrating intense enhancement with flow voids associated with elevated oestrogen levels and virilisation could suggest SLCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.